This study is testing a device called Repetitive, Transorbital Alternating Current Stimulation (rtACS) to see if long-term electrical stimulation is safe and effective for treating open-angle glaucoma. Open-angle glaucoma is a condition where the nerves in the back of your eye die off faster than expected. You may be able to join if you are at least 18 years old and have a diagnosis of glaucoma with a specific level of vision loss (Mean Deviation worse than -3 on a visual field test). The study will measure changes in your vision over 6 months to see if the treatment is successful. The current status of this study is unclear.

Study design

This is an open-label study, meaning both you and the study team will know you are receiving the active treatment. It plans to enroll 40 participants.

What's involved

You would receive treatment every other day via a headband that delivers electrical stimulation. Your visual field will be assessed at the beginning and then again over 6 months.

Compensation

Not stated in the trial record.

Follow-up

Your vision will be monitored for 6 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.